These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8836447)

  • 1. Mazindol: anorectic and behavioral effects in female rats.
    Mattei R; Carlini EA
    Arch Int Pharmacodyn Ther; 1995; 330(3):279-87. PubMed ID: 8836447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
    Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
    Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the anorectic and behavioral effects of fenproporex on male and female rats.
    Mattei R; Carlini EA
    Braz J Med Biol Res; 1996 Aug; 29(8):1025-30. PubMed ID: 9181085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modification of stereotypy-producing and ambulation-increasing effects following repeated administration of methamphetamine in rats].
    Kifune A; Tadokoro S
    Yakubutsu Seishin Kodo; 1991 Jun; 11(3):207-14. PubMed ID: 1771975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated mazindol and methamphetamine administration produces cross-sensitization to stereotyped behavior induced by these agents in rats.
    Kawakami Y; Suemaru K; Araki H; Kawasaki H; Gomita Y; Tanizaki Y
    Acta Med Okayama; 1998 Jun; 52(3):169-71. PubMed ID: 9661745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
    He S; Grasing K
    Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness to methamphetamine in adulthood is altered by prenatal exposure in rats.
    Schutová B; Hrubá L; Pometlová M; Rokyta R; Slamberová R
    Physiol Behav; 2010 Mar; 99(3):381-7. PubMed ID: 20006633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine.
    Witkin JM; Savtchenko N; Mashkovsky M; Beekman M; Munzar P; Gasior M; Goldberg SR; Ungard JT; Kim J; Shippenberg T; Chefer V
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1298-310. PubMed ID: 10027871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological action of mazindol on behaviors and metabolism].
    Nagai K; Mori T; Ookura M; Tsujimoto H; Nakagawa H
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):133-45. PubMed ID: 6745804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats.
    Mizuno M; Kawamura H; Ishizuka Y; Sotoyama H; Nawa H
    Pharmacol Biochem Behav; 2010 Dec; 97(2):392-8. PubMed ID: 20863847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats.
    Carson DS; Cornish JL; Guastella AJ; Hunt GE; McGregor IS
    Neuropharmacology; 2010 Jan; 58(1):38-43. PubMed ID: 19560473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
    Rivière GJ; Byrnes KA; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reverse-tolerance phenomenon in methamphetamine-induced behavioral stereotypy and impairment of cliff avoidance reaction after subchronic methamphetamine administration in rats].
    Yoshida S; Numachi Y; Matsuoka H; Fuse Y; Sato M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Oct; 15(5):397-403. PubMed ID: 8564732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of stereotyped behaviors during prolonged escalation of methamphetamine self-administration in rats.
    Hadamitzky M; McCunney S; Markou A; Kuczenski R
    Psychopharmacology (Berl); 2012 Oct; 223(3):259-69. PubMed ID: 22526541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):169-78. PubMed ID: 7941782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
    Larsen PJ; Vrang N; Petersen PC; Kristensen P
    Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in meal patterns and endogenous chemical determinants related to food intake following intra-ventricle III infusion of mazindol].
    Fujimoto K; Sakata T; Arase K; Tsutsui K; Fukushima M
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):425-32. PubMed ID: 6381262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.